Product Code: ETC6191989 | Publication Date: Sep 2024 | Updated Date: Jun 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Australia`s stomach cancer treatment market is driven by advancements in diagnostic imaging, surgical interventions, and targeted therapies. Despite a relatively low incidence compared to global figures, the market is evolving with the adoption of precision oncology and access to clinical trials for newer immunotherapies.
The stomach cancer treatment market is witnessing growth due to improved diagnostic techniques and new therapies, including targeted drugs and immunotherapies. Clinical research and early detection campaigns are helping improve outcomes and market uptake.
The Australia Stomach Cancer Treatment market is hindered by late-stage diagnosis in most patients, which limits the effectiveness of available therapies. Additionally, the high cost of immunotherapies and limited clinical trial opportunities within the country restrict patient access to innovative treatments.
The stomach cancer treatment market in Australia offers significant opportunities in targeted therapy development, immunotherapy, and diagnostic technologies. Investors can explore pharmaceutical R&D partnerships, biotech innovations, and oncology support service platforms. The rising demand for personalized medicine and government funding for cancer research enhances the attractiveness of this market.
Stomach cancer treatment is supported by the PBS, which lists key chemotherapies, immunotherapies, and anti-nausea medications. National Cancer Control policies guide screening, early detection, and palliative care. While there is no specific stomach cancer screening program, the government funds research through the Cancer Australia initiative.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Stomach Cancer Treatment Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Stomach Cancer Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Stomach Cancer Treatment Market - Industry Life Cycle |
3.4 Australia Stomach Cancer Treatment Market - Porter's Five Forces |
3.5 Australia Stomach Cancer Treatment Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.6 Australia Stomach Cancer Treatment Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
3.7 Australia Stomach Cancer Treatment Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Australia Stomach Cancer Treatment Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.9 Australia Stomach Cancer Treatment Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Australia Stomach Cancer Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Australia Stomach Cancer Treatment Market Trends |
6 Australia Stomach Cancer Treatment Market, By Types |
6.1 Australia Stomach Cancer Treatment Market, By Treatment Type |
6.1.1 Overview and Analysis |
6.1.2 Australia Stomach Cancer Treatment Market Revenues & Volume, By Treatment Type, 2021- 2031F |
6.1.3 Australia Stomach Cancer Treatment Market Revenues & Volume, By Immunotherapy, 2021- 2031F |
6.1.4 Australia Stomach Cancer Treatment Market Revenues & Volume, By Targeted Therapy, 2021- 2031F |
6.1.5 Australia Stomach Cancer Treatment Market Revenues & Volume, By Chemotherapy, 2021- 2031F |
6.1.6 Australia Stomach Cancer Treatment Market Revenues & Volume, By Radiation Therapy And Surgery (Qualitative Analysis Only), 2021- 2031F |
6.2 Australia Stomach Cancer Treatment Market, By Disease Indication |
6.2.1 Overview and Analysis |
6.2.2 Australia Stomach Cancer Treatment Market Revenues & Volume, By Gastric Cancer/Gastroesophageal Junction Cancer, 2021- 2031F |
6.2.3 Australia Stomach Cancer Treatment Market Revenues & Volume, By Gastrointestinal Stromal Tumors, 2021- 2031F |
6.3 Australia Stomach Cancer Treatment Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Australia Stomach Cancer Treatment Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Australia Stomach Cancer Treatment Market Revenues & Volume, By Injectable, 2021- 2031F |
6.4 Australia Stomach Cancer Treatment Market, By Drug Class |
6.4.1 Overview and Analysis |
6.4.2 Australia Stomach Cancer Treatment Market Revenues & Volume, By PD-1/PD-L1 Inhibitors, 2021- 2031F |
6.4.3 Australia Stomach Cancer Treatment Market Revenues & Volume, By HER2 Antagonists, 2021- 2031F |
6.4.4 Australia Stomach Cancer Treatment Market Revenues & Volume, By VEGFR2 Antagonists, 2021- 2031F |
6.4.5 Australia Stomach Cancer Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Australia Stomach Cancer Treatment Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Australia Stomach Cancer Treatment Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.5.3 Australia Stomach Cancer Treatment Market Revenues & Volume, By Specialty & Retail Pharmacies, 2021- 2031F |
6.5.4 Australia Stomach Cancer Treatment Market Revenues & Volume, By Others, 2021- 2031F |
7 Australia Stomach Cancer Treatment Market Import-Export Trade Statistics |
7.1 Australia Stomach Cancer Treatment Market Export to Major Countries |
7.2 Australia Stomach Cancer Treatment Market Imports from Major Countries |
8 Australia Stomach Cancer Treatment Market Key Performance Indicators |
9 Australia Stomach Cancer Treatment Market - Opportunity Assessment |
9.1 Australia Stomach Cancer Treatment Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.2 Australia Stomach Cancer Treatment Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
9.3 Australia Stomach Cancer Treatment Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Australia Stomach Cancer Treatment Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.5 Australia Stomach Cancer Treatment Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Australia Stomach Cancer Treatment Market - Competitive Landscape |
10.1 Australia Stomach Cancer Treatment Market Revenue Share, By Companies, 2024 |
10.2 Australia Stomach Cancer Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |